Morpholino

MO3-fitm2

ID

ZDB-MRPHLNO-160621-20

Name

MO3-fitm2

Previous Names

Target

Sequence

5' - AGGTATTAGACTTGTACTCACAGAT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO3-fitm2

No data available

Phenotype

Phenotype resulting from MO3-fitm2

Phenotype	Fish	Figures
glucose homeostasis disrupted, abnormal	jh1Tg; jh2Tg + MO3-fitm2	Fig. S15 from O'Hare et al., 2016
pancreatic B cell decreased amount, abnormal	jh1Tg; jh2Tg + MO3-fitm2	Fig. 2 from O'Hare et al., 2016
pancreatic B cell decreased area, abnormal	jh1Tg; jh2Tg + MO3-fitm2	Fig. 1 from O'Hare et al., 2016

Phenotype of all Fish created by or utilizing MO3-fitm2

Phenotype	Fish	Conditions	Figures
glucose homeostasis disrupted, abnormal	jh1Tg; jh2Tg + MO3-fitm2	control	Fig. S15 from O'Hare et al., 2016
pancreatic B cell increased amount, abnormal	jh1Tg; jh2Tg + MO3-fitm2	chemical treatment by environment: glucose	Fig. 4 from O'Hare et al., 2016
glucose homeostasis disrupted, abnormal	jh1Tg; jh2Tg + MO3-fitm2	chemical treatment by environment: glucose	Fig. S15 from O'Hare et al., 2016
pancreatic B cell decreased amount, abnormal	jh1Tg; jh2Tg + MO3-fitm2	standard conditions	Fig. 2 from O'Hare et al., 2016
pancreatic B cell decreased area, abnormal	jh1Tg; jh2Tg + MO3-fitm2	standard conditions	Fig. 1 from O'Hare et al., 2016
pancreatic B cell regeneration decreased rate, abnormal	jh4Tg + MO3-fitm2	chemical ablation: pancreatic B cell, chemical treatment by environment: metronidazole	Fig. 5 from O'Hare et al., 2016

Citations